2.Immunological Markers for Central Nervous System Glia.
Hao HUANG ; Wanjun HE ; Tao TANG ; Mengsheng QIU
Neuroscience Bulletin 2023;39(3):379-392
Glial cells in the central nervous system (CNS) are composed of oligodendrocytes, astrocytes and microglia. They contribute more than half of the total cells of the CNS, and are essential for neural development and functioning. Studies on the fate specification, differentiation, and functional diversification of glial cells mainly rely on the proper use of cell- or stage-specific molecular markers. However, as cellular markers often exhibit different specificity and sensitivity, careful consideration must be given prior to their application to avoid possible confusion. Here, we provide an updated overview of a list of well-established immunological markers for the labeling of central glia, and discuss the cell-type specificity and stage dependency of their expression.
Neuroglia/metabolism*
;
Central Nervous System
;
Oligodendroglia/metabolism*
;
Astrocytes/metabolism*
;
Microglia
3.Advances in basic research on choline and central nervous system development and related disorders.
Zheng Long XIA ; Xu Ying TAN ; Yan Yan SONG
Chinese Journal of Preventive Medicine 2023;57(5):793-800
Choline is an essential nutrient that plays an integral role in all stages of the life cycle, with increasing interest in the relationship between choline and neurodevelopment. Choline is a major component in the synthesis of phospholipids, phosphatidylcholine and sphingolipids, and is an essential nutrient for methyl metabolism, acetylcholine synthesis and cell signaling. Choline plays an important role in neurogenesis and neural migration during fetal development, potentially influencing the development and prognosis of neurological disorders, but its mechanism of action is not yet clear. This article reviews the source and metabolism of choline, the effects and mechanism of choline on neurodevelopment and central nervous system related disorders.
Humans
;
Choline/metabolism*
;
Phosphatidylcholines/metabolism*
;
Central Nervous System/metabolism*
4.Effects of bisphenol A and bisphenol analogs on the nervous system.
Chunxia LI ; Chen SANG ; Shuo ZHANG ; Sai ZHANG ; Hui GAO
Chinese Medical Journal 2023;136(3):295-304
Estrogen impacts neural development; meanwhile, it has a protective effect on the brain. Bisphenols, primarily bisphenol A (BPA), can exert estrogen-like or estrogen-interfering effects by binding with estrogen receptors. Extensive studies have suggested that neurobehavioral problems, such as anxiety and depression, can be caused by exposure to BPA during neural development. Increasing attention has been paid to the effects on learning and memory of BPA exposure at different developmental stages and in adulthood. Further research is required to elucidate whether BPA increases the risk of neurodegenerative diseases and the underlying mechanisms, as well as to assess whether BPA analogs, such as bisphenol S and bisphenol F, influence the nervous system.
Receptors, Estrogen/metabolism*
;
Estrogens
;
Benzhydryl Compounds/pharmacology*
;
Nervous System/metabolism*
5.Role of N6-methyladenosine RNA methylation in central nervous system: a review.
Chinese Journal of Biotechnology 2023;39(1):45-59
There are a variety of post-transcriptional modifications in mRNA, which regulate the stability, splicing, translation, transport and other processes of mRNA, followed by affecting cell development, body immunity, learning and cognition and other important physiological functions. m6A modification is one of the most abundant post-transcriptional modifications widely existing in mRNA, regulating the metabolic activities of RNA and affecting gene expression. m6A modified homeostasis is critical for the development and maintenance of the nervous system. In recent years, m6A modification has been found in neurodegenerative diseases, mental diseases and brain tumors. This review summarizes the role of m6A methylation modification in the development, function and related diseases of the central nervous system in recent years, providing potential clinical therapeutic targets for neurological diseases.
Methylation
;
Central Nervous System/metabolism*
;
RNA, Messenger/metabolism*
;
RNA
6.LIM kinases and their roles in the nervous system.
Ru-yi ZHANG ; Yue-min DING ; Li-huang ZHANG
Journal of Zhejiang University. Medical sciences 2014;43(1):119-125
LIM kinase-1 (LIMK1) and LIM kinase-2 (LIMK2) are kinases that have serine/threonine and tyrosine dual specificity. Although they show significant structural similarity, LIMK1 and LIMK2 have different expression patterns, subcellular localization, and functions. Activation of LIM kinases regulates the downstream of Rho GTPases, and influences the architecture of the actin cytoskeleton by regulating the activity of cofilin. Recent studies have shown that LIM kinases play important roles in the nervous system. For example, development of the central nervous system is reliant upon the presence of LIMK1, and deletion of Limk1 gene is involved in the development of the human genetic disorder Williams syndrome. Therefore, it is of vital physiological significance to investigate the neuronal function of LIM kinases. In this review, we outline the structure, phosphorylation regulation and neuronal function of LIM kinases, so as to provide new ideas for the treatment of these neurological diseases.
Animals
;
Humans
;
Lim Kinases
;
chemistry
;
metabolism
;
physiology
;
Nervous System
;
enzymology
7.Hydrogen sulfide and nervous system regulation.
Cheng-Fang ZHOU ; Xiao-Qing TANG
Chinese Medical Journal 2011;124(21):3576-3582
OBJECTIVEThis review discusses the current status and progress in studies on the roles of hydrogen sulfide (H(2)S) in regulation of neurotoxicity, neuroprotection, and neuromodulator, as well as its therapeutic potential for neurodegenerative disorders.
DATA SOURCESThe data used in this review were mainly from Medline and PubMed published in English from 2001 to August 2011. The search terms were "hydrogen sulfide", "neuron", and "neurodegenerative disorders".
STUDY SELECTIONArticles regarding the regulation of neuronal function, the protection against neuronal damage and neurological diseases, and their possible cellular and molecular mechanisms associated with H(2)S were selected.
RESULTSThe inhibited generation of endogenous H(2)S is implicated in 1-methy-4-phenylpyridinium ion, 6-OHDA, and homocysteine-triggered neurotoxicity. H(2)S elicits neuroprotection in Alzheimer's disease and Parkinson's disease models as well as protecting neurons against oxidative stress, ischemia, and hypoxia-induced neuronal death. H(2)S offers anti-oxidant, anti-inflammatory and anti-apoptotic effects, as well as activates ATP-sensitive potassium channels and cystic fibrosis transmembrane conductance regulator Cl- channels. H(2)S regulates the long-term potentiation (LTP) and GABAB receptors in the hippocampus, as well as intracellular calcium and pH homeostasis in neurons and glia cells.
CONCLUSIONSThese articles suggest that endogenous H(2)S may regulate the toxicity of neurotoxin. H(2)S not only acts as a neuroprotectant but also serves as a novel neuromodulator.
Animals ; Humans ; Hydrogen Sulfide ; metabolism ; Nervous System ; metabolism ; Neuroprotective Agents ; metabolism ; Neurotoxins ; metabolism ; Neurotransmitter Agents ; metabolism
8.Expression of connexin 36 in central nervous system and its role in epileptic seizure.
Yu-Fen PENG ; Jiong-Xing WU ; Heng YANG ; Xuan-Qi DONG ; Wen ZHENG ; Zhi SONG
Chinese Medical Journal 2012;125(13):2365-2370
OBJECTIVEThis review discusses the experimental and clinical studies those show the expression of connexin 36 in the central nervous system and the possible role of connexin 36 in epileptic seizure.
DATA SOURCESAll articles used in this review were mainly searched from PubMed published in English from 1996 to 2012.
STUDY SELECTIONOriginal articles and reviews were selected if they were related to the expression of connexin 36 in the central nervous system and its role in epilepsy.
RESULTSThe distribution of connexin 36 is developmentally regulated, cell-specific and region-specific. Connexin 36 is involved in some neuronal functions and epileptic synchronization. Changes in the connexin 36 gene and protein were accompanied by seizures. Selective gap junction blockers have exerted anticonvulsant actions in a variety of experiments examined in both humans and experimental animals.
CONCLUSIONSConnexin 36 plays an important role in both physiological and pathological conditions in the central nervous system. A better understanding of the role of connexin 36 in seizure activity may contribute to the development of new therapeutic approaches to treating epilepsy.
Animals ; Central Nervous System ; metabolism ; Connexins ; metabolism ; Gap Junctions ; metabolism ; Humans ; Seizures ; metabolism
9.Roles of NG2 Glia in Cerebral Small Vessel Disease.
Yixi HE ; Zhenghao LI ; Xiaoyu SHI ; Jing DING ; Xin WANG
Neuroscience Bulletin 2023;39(3):519-530
Cerebral small vessel disease (CSVD) is one of the most prevalent pathologic processes affecting 5% of people over 50 years of age and contributing to 45% of dementia cases. Increasing evidence has demonstrated the pathological roles of chronic hypoperfusion, impaired cerebral vascular reactivity, and leakage of the blood-brain barrier in CSVD. However, the pathogenesis of CSVD remains elusive thus far, and no radical treatment has been developed. NG2 glia, also known as oligodendrocyte precursor cells, are the fourth type of glial cell in addition to astrocytes, microglia, and oligodendrocytes in the mammalian central nervous system. Many novel functions for NG2 glia in physiological and pathological states have recently been revealed. In this review, we discuss the role of NG2 glia in CSVD and the underlying mechanisms.
Animals
;
Neuroglia/metabolism*
;
Central Nervous System/metabolism*
;
Astrocytes/metabolism*
;
Oligodendroglia/metabolism*
;
Cerebral Small Vessel Diseases/metabolism*
;
Antigens/metabolism*
;
Mammals/metabolism*
10.Research advances on hydrogen therapy in nervous system diseases.
Yuan HONG ; Sheng CHEN ; Jian-min ZHANG
Journal of Zhejiang University. Medical sciences 2010;39(6):638-643
Oxidative stress plays a pivotal role in the pathogenesis of varied nervous system diseases. Recent studies have demonstrated that hydrogen has selective antioxidative effect. It selectively reduces the hydroxyl radical (*OH) and peroxynitrite (ONOO(-)), the most cytotoxic of reactive oxygen species (ROS); however, it does not affect other ROS, which play important physiological roles at low concentrations. A large body of experimental studies has proved that hydrogen, through anti-oxidation, anti-inflammatory and inhibiting apoptosis, has a significant therapeutic effect in various neurological diseases, such as ischemia, hypoxia, degeneration and spinal cord contusion. It provides us with a new clinical method for the prevention and treatment of neurological diseases.
Antioxidants
;
pharmacology
;
Humans
;
Hydrogen
;
pharmacology
;
Hydroxyl Radical
;
metabolism
;
Nervous System
;
drug effects
;
metabolism
;
Nervous System Diseases
;
drug therapy
;
metabolism
;
Oxidative Stress
;
drug effects
;
physiology
;
Peroxynitrous Acid
;
metabolism